Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Yanal M. Murad
Observed names:
Murad, Y.M.,
Y M Murad,
Y Murad,
Yana Murad,
Yanal M Murad,
Yanal Murad
show all 6
Observed institutions:
Rush University Medical Center,
University of British Columbia,
Duke University,
Health Sciences North,
Institute for Biological Sciences,
Duke Medical Center,
National Research Council Canada,
City of Vancouver,
Rush University,
NOSM University
show all 10
ORCID:
0000-0003-2792-3932
Observed ORCID:
0000-0003-2792-3932
OpenAlex ID:
A5074390824
mRNA vaccines encoding fusion proteins of monkeypox virus antigens protect mice from vaccinia virus challenge
2023
·
Fujun Hou
, Yuntao Zhang
, et al.
·
Nature Communications
·
112
PDF
CpG Oligodeoxyneucleotides as TLR9 Agonists
2009
·
Yanal M. Murad
, Timothy M. Clay
·
BioDrugs
·
109
Oncolytic virus VG161 in refractory hepatocellular carcinoma
2025
·
Yinan Shen
, Xueli Bai
, et al.
·
Nature
·
97
Cartilage‐specific constitutive expression of TSG‐6 protein (product of tumor necrosis factor α–stimulated gene 6) provides a chondroprotective, but not antiinflammatory, effect in antigen‐induced arthritis
2002
·
Tibor T. Glant
, Rajesh V. Kamath
, et al.
·
Arthritis & Rheumatism
·
82
Induction of Durable Antitumor Response by a Novel Oncolytic Herpesvirus Expressing Multiple Immunomodulatory Transgenes
2020
·
Dmitry V. Chouljenko
, Jun Ding
, et al.
·
Biomedicines
·
62
PDF
CPG-7909 (PF-3512676, ProMune®): toll-like receptor-9 agonist in cancer therapy
2007
·
Yanal M Murad
, Timothy M Clay
, et al.
·
Expert Opinion on Biological Therapy
·
56
Stable Expression of Chimeric Heavy Chain Antibodies in CHO Cells
2012
·
Vishal Agrawal
, Igor Slivac
, et al.
·
Methods in molecular biology
·
45
T-cell recognition of differentially tolerated epitopes of cartilage proteoglycan aggrecan in arthritis
2005
·
Edit I. Buzás
, Anikó Végvári
, et al.
·
Cellular Immunology
·
42
Single domain antibody against carcinoembryonic antigen-related cell adhesion molecule 6 (CEACAM6) inhibits proliferation, migration, invasion and angiogenesis of pancreatic cancer cells
2012
·
Tsai-Mu Cheng
, Yanal M. Murad
, et al.
·
European Journal of Cancer
·
40
VG161 activates systemic antitumor immunity in pancreatic cancer models as a novel oncolytic herpesvirus expressing multiple immunomodulatory transgenes
2022
·
Yinan Shen
, Wei Song
, et al.
·
Journal of Medical Virology
·
37
PDF
Pre-Existing HSV-1 Immunity Enhances Anticancer Efficacy of a Novel Immune-Stimulating Oncolytic Virus
2022
·
Jun Ding
, Yanal M. Murad
, et al.
·
Viruses
·
33
PDF
Molecular targeting of CEACAM6 using antibody probes of different sizes
2012
·
Gang Niu
, Yanal M. Murad
, et al.
·
Journal of Controlled Release
·
25
False Negative Results in Clostridium difficile Testing
2016
·
Yanal M. Murad
, Justo Perez
, et al.
·
BMC Infectious Diseases
·
22
PDF
Isolation of functional single domain antibody by whole cell immunization: Implications for cancer treatment
2011
·
Toya Nath Baral
, Yanal Murad
, et al.
·
Journal of Immunological Methods
·
20
Differential Recognition of Altered Peptide Ligands Distinguishes Two Functionally Discordant (Arthritogenic and Nonarthritogenic) Autoreactive T Cell Hybridoma Clones
2003
·
Edit I Buzás
, Anita Hanyecz
, et al.
·
The Journal of Immunology
·
20
PDF
Impact of polymerase chain reaction testing on Clostridium difficile infection rates in an acute health care facility
2015
·
Yanal M. Murad
, Justo Perez
, et al.
·
American Journal of Infection Control
·
17
PDF
Targeting carcinoembryonic antigen-expressing tumors using a novel transcriptional and translational dual-regulated oncolytic herpes simplex virus type 1
2023
·
Dmitry V. Chouljenko
, Yanal M. Murad
, et al.
·
Molecular Therapy — Oncolytics
·
15
Molecular manipulation with the arthritogenic epitopes of the G1 domain of human cartilage proteoglycan aggrecan
2005
·
Y M Murad
, Z Szabó
, et al.
·
Clinical & Experimental Immunology
·
14
Evaluating the immunogenicity of an intranasal vaccine against nicotine in mice using the Adjuvant Finlay Proteoliposome (AFPL1)
2016
·
Nya L. Fraleigh
, Justin Boudreau
, et al.
·
Heliyon
·
12
PDF
Clinical outcomes from a phase I clinical trial of a novel oncolytic virus VG161 in patients with hepatocellular carcinoma (HCC) refractory after 2 prior lines of therapy including checkpoint inhibitors (CPI).
2024
·
Yinan Shen
, Xingmei Liang
, et al.
·
Journal of Clinical Oncology
·
11
PDF
Complete Genome Sequence of Enterococcus thailandicus Strain a523 Isolated from Urban Raw Sewage
2017
·
Gustavo Ybazeta
, Laura Douglas
, et al.
·
Genome Announcements
·
11
PDF
The Effect of Nisin on the Physiology of Bifidobacterium thermophilum
2001
·
Eva Kot
, Yanal Murad
, et al.
·
Journal of Food Protection
·
7
Oncolytic virotherapy stimulates anti‑tumor immune response and demonstrates activity in advanced sarcoma: Report of two cases
2024
·
Yeting Qiu
, Aijun Qin
, et al.
·
Oncology Letters
·
5
PDF
Initial results from a first in human trial incorporating accelerated dose titration of a novel immune stimulating oncolytic virus - VG161.
2021
·
Ronghua Zhao
, Rasha Cosman
, et al.
·
Journal of Clinical Oncology
·
5
Prophylactic Vaccination and Intratumoral Boost with HER2-Expressing Oncolytic Herpes Simplex Virus Induces Robust and Persistent Immune Response against HER2-Positive Tumor Cells
2023
·
Zahid Delwar
, Olga Tatsiy
, et al.
·
Vaccines
·
4
PDF
Show more works
View as search
Works count:
37
Citation count:
910
H-index:
16
I10-index:
21
Year
Topic
Type
